1. Home
  2. FULC vs CINT Comparison

FULC vs CINT Comparison

Compare FULC & CINT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Fulcrum Therapeutics Inc.

FULC

Fulcrum Therapeutics Inc.

HOLD

Current Price

$7.57

Market Cap

718.4M

Sector

Health Care

ML Signal

HOLD

Logo CI&T Inc

CINT

CI&T Inc

HOLD

Current Price

$5.41

Market Cap

566.6M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
FULC
CINT
Founded
2015
1995
Country
United States
Brazil
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
EDP Services
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
718.4M
566.6M
IPO Year
2019
2021

Fundamental Metrics

Financial Performance
Metric
FULC
CINT
Price
$7.57
$5.41
Analyst Decision
Buy
Strong Buy
Analyst Count
8
5
Target Price
$16.38
$7.02
AVG Volume (30 Days)
1.1M
90.8K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$14.06
Revenue Next Year
N/A
$11.51
P/E Ratio
N/A
$17.94
Revenue Growth
N/A
N/A
52 Week Low
$2.32
$3.98
52 Week High
$15.74
$6.71

Technical Indicators

Market Signals
Indicator
FULC
CINT
Relative Strength Index (RSI) 32.65 60.02
Support Level $7.40 $5.26
Resistance Level $7.64 $5.51
Average True Range (ATR) 0.64 0.24
MACD -0.10 0.05
Stochastic Oscillator 1.01 56.08

Price Performance

Historical Comparison
FULC
CINT

About FULC Fulcrum Therapeutics Inc.

Fulcrum Therapeutics Inc is a clinical-stage biopharmaceutical company. The company's programs in clinical development are losmapimod, a small molecule for the treatment of facioscapulohumeral muscular dystrophy (FSHD) and FTX-6058, a small molecule designed to increase expression of fetal hemoglobin for the treatment of sickle cell disease and other hemoglobinopathies, including beta-thalassemia.

About CINT CI&T Inc

CI&T Inc is engaged in providing plans, design, and software engineering services to enable digital transformation for companies. The company mainly develops customizable software through the implementation of several software solutions, including Machine Learning, Artificial Intelligence (AI), Analytics, Cloud, and Mobility technologies. The majority of the revenue is generated from the North America and Europe, followed by Asia, Pacific and Japan.

Share on Social Networks: